Biogen will be filing for EU approval as well shortly. A response regarding the acceptance of the NDA should be out in a couple of months. We believe BG-12 could become a leader in the oral ...

BG-12 (dimethyl fumarate) was shown to have antiinflammatory and cytoprotective properties in preclinical experiments and to result in significant reductions in disease activity on magnetic resonan ...

April 12, 2011 — Phase 3 results with oral BG-12 (dimethyl fumarate; Biogen Idec) in relapsing-remitting multiple sclerosis (RRMS) show significant clinical responses and favorable safety and ...

Some of the analysts following Biogen Idec's late-stage oral MS drug BG-12 were nodding in approval today as the big biotech laid out a full set of data that confirms the efficacy already reported.

Biogen Idec's oral BG-12 handily outstripped Teva's Copaxone in a Phase III study for multiple sclerosis, setting up a direct march to the FDA with positive late-stage data covering 2,600 patients.

A Ring doorbell camera in Peosta, Iowa, captured a bright meteor from the Eta Aquarids shower in the early hours of 12 May. Nurse Kurt Massimilla, 56, spotted the streak on footage triggered by a ...

Purchasing a digital camera during the holidays? Here's the background info you'll need before plopping down your ducats.